SCHEMBL4345686

SCHEMBL4345686

O=[N+]([O-])c1cc(F)c(O)c(NCc2ccccc2Sc2ccc(Cl)cc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.41
MAPT P10636 7/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
PLA2G1B P04054 1/20 0.41
ATG4B Q9Y4P1 1/20 0.41
ALDH1A1 P00352 3/20 0.40
GAA P10253 1/20 0.40
PKM P14618 1/20 0.40
NPC1 O15118 1/20 0.39
HTT P42858 2/20 0.39
LMNA P02545 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
BLM P54132 1/20 0.38
NOD2 Q9HC29 1/20 0.38
BCL2L1 Q07817 1/20 0.38
PDE7A Q13946 2/20 0.38
PDE7B Q9NP56 1/20 0.38
IDO1 P14902 1/20 0.38
ALDH3A1 P30838 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4345853 0.93 MAPT (0.41) SLC6A4MAPTMEN1KMT2APLA2G1B
SCHEMBL4350287 0.92 MAPT (0.41) SLC6A4MAPTMEN1KMT2APLA2G1B
SCHEMBL4349817 0.90 SLC6A4 (0.45) SLC6A4MAPTMEN1KMT2APLA2G1B
SCHEMBL4345417 0.90 SLC6A4 (0.42) SLC6A4MAPTMEN1KMT2APLA2G1B
SCHEMBL4347132 0.90 MAPT (0.43) MAPTMEN1KMT2APLA2G1BATG4B
SCHEMBL4342384 0.90 MAPT (0.41) SLC6A4MAPTMEN1KMT2AALDH1A1
SCHEMBL4351077 0.89 SLC6A4 (0.47) SLC6A4MAPTMEN1KMT2APLA2G1B
SCHEMBL4342390 0.87 PDE7A (0.44) MAPTMEN1KMT2AALDH1A1GAA
SCHEMBL4358425 0.87 MEN1 (0.49) MAPTMEN1KMT2AALDH1A1GAA
SCHEMBL4345875 0.85 MAPT (0.42) MAPTMEN1KMT2AALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
CN-1701061-A Novel compounds for inhibiting rotamase enzymes and uses thereof JERINI AG (DE) 2005-11-23 CN claimed
EP-1539683-A2 PHENOL DERIVATIVES AND THEIR USE AS ROTAMASE INHIBITORS Jerini AG (DE) 2005-06-15 EP claimed
WO-2004030664-A2 NEW COMPOUNDS FOR THE INHIBITION OF UNDESIRED CELL PROLIFERATION AND USE THEREOF JERINI AG (DE) 2004-04-15 WO claimed
WO-2004026815-A2 PHENOL DERIVATIVES AND THEIR USE AS ROTAMASE INHIBITORS JERINI AG (DE) 2004-04-01 WO claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 SLC6A4 1100/4885MAPT 4439/4885MEN1 2168/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 SLC6A4 1325/4885MAPT 4184/4885MEN1 3901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.